Search Medical Condition
Please enter condition
Please choose location from dropdown

Elevated Triglycerides (Hypertriglyceridemia) Clinical Trials

A listing of Elevated Triglycerides (Hypertriglyceridemia) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (33) clinical trials

At risk for heart conditions? Diabetes? High triglycerides? Global Medical Research is looking for individuals with cardiovascular issues and diabetes with high triglycerides for a clinical research study of an investigational medication.

Phase N/A

This study will compare pemafibrate (K-877) compared to placebo to discover if pemafibrate lowers cardiovascular complications such as heart attack, stroke, and death from these conditions in adults with Type II Diabetes mellitus who have elevated triglycerides and low high-density lipoprotein cholesterol (HDL-C "good cholesterol). The study will also test ...

Phase

People with these conditions have a higher risk of heart attack or stroke in the future. Because we know who is at a greater risk, we want to take early steps to try to prevent a cardiovascular emergency. The Aleprevent clinical research study will look at whether an investigational medication ...

Phase N/A

To determine the efficacy of CaPre 4 g daily, compared to placebo, in lowering fasting triglyceride (TG) levels in patients with fasting TG levels ≥500 mg/dL and ≤1500 mg/dL (≥5.7 mmol/L and ≤17.0 mmol/L) after 12 weeks of treatment.

Phase

The primary objective of the study is to determine whether pemafibrate administered twice daily will delay the time to first occurrence of any component of the clinical composite endpoint of: nonfatal Myocardial Infarction (MI) nonfatal ischemic stroke hospitalization for unstable angina requiring unplanned coronary revascularization; or Cardio Vascular (CV) death.

Phase N/A

The primary objective of the study is to determine whether pemafibrate administered twice daily will delay the time to first occurrence of any component of the clinical composite endpoint of: nonfatal Myocardial Infarction (MI) nonfatal ischemic stroke hospitalization for unstable angina requiring unplanned coronary revascularization; or Cardio Vascular (CV) death. ...

Phase N/A

The purpose of this study is to determine whether CaPre® 4g daily can help lower fasting triglyceride (a kind of fat in the blood) levels. The safety and tolerability of CaPre® will also be assessed. In addition, this study will compare CaPre® 4g daily with placebo, a substance that looks like ...

Phase

To access the efficacy, safety and tolerability of Gemcabene in subjects with severe hypertriglyceridemia.

Phase N/A

To evaluate the efficacy and safety of K-877 in subjects with fasting triglyceride levels ≥500mg/dL and <2000 mg/dL and normal renal function. Duration of study is 52 weeks on study drug.

Phase N/A